Dumont & Blake Investment Advisors LLC decreased its position in shares of MetLife, Inc. (NYSE:MET – Free Report) by 0.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 30,311 shares of the financial services provider’s stock after selling 211 shares during the quarter. Dumont & Blake Investment Advisors LLC’s holdings in MetLife were worth $2,482,000 at the end of the most recent reporting period.
Several other hedge funds also recently modified their holdings of MET. Swedbank AB lifted its position in shares of MetLife by 76.0% in the 4th quarter. Swedbank AB now owns 3,466,808 shares of the financial services provider’s stock worth $283,862,000 after purchasing an additional 1,496,645 shares during the period. Zurich Insurance Group Ltd FI acquired a new position in MetLife during the 3rd quarter worth approximately $91,771,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. grew its position in MetLife by 79.1% in the 3rd quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 1,726,209 shares of the financial services provider’s stock valued at $142,378,000 after purchasing an additional 762,291 shares during the period. Jacobs Levy Equity Management Inc. grew its holdings in shares of MetLife by 256.6% during the third quarter. Jacobs Levy Equity Management Inc. now owns 948,223 shares of the financial services provider’s stock valued at $78,209,000 after buying an additional 682,333 shares during the last quarter. Finally, Nordea Investment Management AB lifted its position in MetLife by 16.8% in the 4th quarter. Nordea Investment Management AB now owns 4,238,087 shares of the financial services provider’s stock valued at $347,735,000 after acquiring an additional 608,224 shares in the last quarter. Institutional investors and hedge funds own 94.99% of the company’s stock.
Wall Street Analysts Forecast Growth
Several brokerages have recently commented on MET. Wells Fargo & Company lowered their price objective on MetLife from $93.00 to $92.00 and set an “overweight” rating for the company in a research note on Tuesday, January 14th. BMO Capital Markets started coverage on MetLife in a research report on Thursday, January 23rd. They issued a “market perform” rating and a $97.00 price target for the company. StockNews.com downgraded shares of MetLife from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. TD Cowen increased their target price on shares of MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a report on Wednesday, November 27th. Finally, Barclays increased their price objective on shares of MetLife from $90.00 to $96.00 and gave the company an “overweight” rating in a research note on Monday, January 6th. Two research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $90.46.
MetLife Stock Up 0.5 %
MetLife stock opened at $87.07 on Friday. The firm has a market capitalization of $60.29 billion, a price-to-earnings ratio of 17.55, a P/E/G ratio of 0.66 and a beta of 1.07. MetLife, Inc. has a 1-year low of $64.61 and a 1-year high of $89.05. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51. The firm has a 50 day simple moving average of $84.03 and a 200 day simple moving average of $80.35.
MetLife Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Investors of record on Tuesday, February 4th will be paid a dividend of $0.545 per share. The ex-dividend date of this dividend is Tuesday, February 4th. This represents a $2.18 annualized dividend and a yield of 2.50%. MetLife’s dividend payout ratio is currently 43.95%.
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
- Five stocks we like better than MetLife
- Short Selling – The Pros and Cons
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- How to Calculate Inflation Rate
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.